We are studying whether atezolizumab can help patients with muscle-invasive bladder cancer who cannot have surgery after chemo-radiotherapy. The trial looks at how well it works and its impact on patients' quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Muscle-invasive bladder cancer (MIBC) is a type of cancer that starts in the bladder and has spread into the muscle layer of the bladder wall, often requiring more aggressive treatment. Symptoms may include blood in urine, frequent urination, and pelvic pain.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.